Atea Pharmaceuticals, Inc.
AVIR
$3.09
$0.0250.82%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.35% | 6.01% | -43.78% | -78.11% | -13.75% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.28% | 18.62% | 12.01% | -3.70% | -9.64% |
| Change in Net Operating Assets | -190.74% | -121.08% | -447.56% | 458.37% | 127.56% |
| Cash from Operations | -39.22% | -30.95% | -161.80% | -33.55% | -1.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -112.13% | -108.52% | 167.77% | 132.03% | -17.07% |
| Cash from Investing | -112.13% | -108.52% | 167.77% | 132.03% | -17.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 27.17% | -- | -9.09% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 27.17% | -- | -9.09% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -668.76% | -90.67% | 170.93% | 428.28% | -50.29% |
